Interest Expense in USD of Pasithea Therapeutics Corp. from 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Pasithea Therapeutics Corp. quarterly/annual Interest Expense history and growth rate from 2021 to Q2 2023.
  • Pasithea Therapeutics Corp. Interest Expense for the quarter ending June 30, 2023 was -$117K.
  • Pasithea Therapeutics Corp. annual Interest Expense for 2022 was $102.000, a 79.9% decline from 2021.
Interest Expense, Quarterly (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)

Pasithea Therapeutics Corp. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$117K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $6.39K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12

Pasithea Therapeutics Corp. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $102 -$406 -79.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $508 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.